热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Alexa Fluor® 700 anti-mouse/human CD11b Antibo
产品名称：
Alexa Fluor® 700 anti-mouse/human CD11b Antibo
产品类别：
抗体
产品编号：
101222
产品应用：
101222
[价格]
规格 价格 库存
100µg ￥ 2580 1

产品详情

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633nm / 635nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Clone M1/70 has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  36. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  2. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  3. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  4. Gawish R, et al. 2022. Elife. 11:. PubMed
  5. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  6. Aggen DH, et al. 2020. Clin Cancer Res. . PubMed
  7. Israelow B, et al. 2020. bioRxiv. . PubMed
  8. Metushi I, et al. 2014. Drug Metab Dispos. 42:963. PubMed
  9. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  10. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  11. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  12. Hahn J, et al. 2020. Brain Behav Immun. 87:329. PubMed
  13. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  14. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  15. Cluny NL, et al. 2022. J Neuroinflammation. 19:73. PubMed
  16. Sykes DB et al. 2016. Cell. 167(1):171-186 . PubMed
  17. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  18. Reyes RM, et al. 2021. Oncoimmunology. 10:2006529. PubMed
  19. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  20. Renga G, et al. 2020. Life Sci Alliance. 3:. PubMed
  21. Getts D, et al. 2014. Sci Transl Med. 15:219. PubMed
  22. Li B, et al. 2017. Am J Physiol Renal Physiol. 312(1):F43-F53. PubMed
  23. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  24. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  25. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  26. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  27. Perelman SS, et al. 2021. Nat Microbiol. 6:731. PubMed
  28. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  29. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  30. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  31. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  32. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  33. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  34. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  35. Kim P, et al. 2015. J Exp Med. 212:633. PubMed
  36. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  37. Jackson-Jones LH, et al. 2020. Immunity. 52:700. PubMed
  38. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  39. Searles S, et al. 2013. J Immunol. 191:3884. PubMed
  40. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  41. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  42. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  43. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  44. Boehm DT, et al. 2018. Infect Immun. 86:. PubMed
  45. Devaraj A, et al. 2021. J Clin Invest. 131:. PubMed
  46. Matundan H, et al. 2019. J Virol. 93. PubMed
  47. Hu Q, et al. 2020. Cell Death Dis. 1.100694444. PubMed
  48. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  49. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  50. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  51. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  52. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  53. Taylor D, et al. 2022. Front Immunol. 13:936129. PubMed
  54. Pizzolla A, et al. 2016. PLoS One. 11: 0160407. PubMed
  55. Boehm DT, et al. 2019. NPJ Vaccines. 4:40. PubMed
  56. Wingert S, et al. 2021. MAbs. 13:1950264. PubMed
  57. Hoyt T, et al. 2015. Infect Immun . 83:743. PubMed
  58. Zhao Y et al. 2018. Cell reports. 24(2):379-390 . PubMed
  59. NULL, et al. 2022. Cell. 185:916. PubMed
  60. Ni X, et al. 2022. Front Immunol. 13:773291. PubMed
  61. Soberanes S et al. 2018. Cell metabolism. 29(2):335-347 . PubMed
  62. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  63. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  64. Yun H, et al. 2020. Immunity. 53(5):1050-1062.e5. PubMed
  65. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  66. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  67. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  68. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  69. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  70. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  71. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  72. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  73. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  74. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  75. Prigge J, et al. 2015. J Immunol. 195: 5347 - 5357. PubMed
  76. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  77. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  78. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  79. Gawish R, et al. 2022. Elife. 11:. PubMed
  80. Ehrens A, et al. 2021. Cell Reports. 34(2):108621. PubMed
  81. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  82. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  83. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  84. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  85. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  86. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  87. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
RRID
AB_493705 (BioLegend Cat. No. 101222)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线